A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis

Completed · Phase 4

Conditions studied: Conjunctivitis, Allergic

In brief

To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center, double-masked, randomized, placebo controlled parallel treatment conjunctival allergen challenge (CAC) study in patients with allergic conjunctivitis

Key facts

Study ID

NCT00655109

Run by

Greiner, Jack V., OD DO PhD

People needed

60

Starts

2008-02-01

Expected to finish

2008-03-01

Last updated by the study team

2008-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age \& either sex, any race
• Willing and able to follow all instructions and attend all study visits
• Positive history of ocular allergies
• Reproducible positive ocular allergic reaction induced by conjunctival allergen challenge

You may not qualify if…

• Have planned surgery during trial period
• Female currently pregnant, planning a pregnancy, or lactating
• Use of disallowed medications

Where it is running

• Ophthalmic Research Associates, Inc — North Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.